Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine.
about
Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
name
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@ast
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@en
type
label
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@ast
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@en
prefLabel
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@ast
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@en
P2093
P2860
P356
P1433
P1476
Clinical implications of ribon ...... chemotherapy with gemcitabine.
@en
P2093
Koichiro Yamaoku
Makoto Ueno
Manabu Morimoto
Manabu Shiozawa
Masaaki Murakawa
Munetaka Masuda
Norio Yukawa
Soichiro Morinaga
Takaki Yoshikawa
Takashi Oshima
P2860
P304
P356
10.3892/OL.2017.5935
P577
2017-03-28T00:00:00Z